Investors might want to bet on MAIA Biotechnology, Inc. (MAIA), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

In this article, we are going to take a look at where MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) stands against other cheapest stocks insiders are buying in March. After solid gains Monday ...

Morningstar brands and products Company Portfolio ...

Diamond Equity also issued estimates for MAIA Biotechnology’s Q2 2025 earnings at ($0.25) EPS, Q3 2025 earnings at ($0.19) EPS, Q4 2025 earnings at ($0.13) EPS and FY2025 earnings at ($0.75) EPS ...

We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look at where MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) stands against other ...

MAIA’s letter to shareholders is available at ir.maiabiotech.com. About MAIA Biotechnology, Inc. MAIA is a targeted therapy, immuno-oncology company focused on the development and ...

Earnings Estimate Revisions for MAIA Biotechnology, Inc. This company is expected to earn -$0.75 per share for the fiscal year ending December 2025, which represents no year-over-year change ...

Investors might want to bet on MAIA Biotechnology, Inc. (MAIA), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...